Concepedia

Zachary Cartun

ZC

Statistics

Publications

4

Citations

638

H-Index

4

Active since

2018

Affiliations

Dana-Farber Brigham Cancer Center(Current)

Dana-Farber Cancer Institute

Broad Institute

Harvard University

Brigham and Women's Hospital

Zachary Cartun is an author at Dana-Farber Brigham Cancer Center specializing in oncology, life sciences, and molecular oncology.

Publications per year

2018–2022

4

Publications

4

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

Romain Guièze, Vivian M. Liu, Daniel Rosebrock et al. · Cancer Cell · 2019 · 360 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Sachet A. Shukla, Pavan Bachireddy, Bastian Schilling et al. · Cell · 2018 · 172 citations · Full text

Life Sciences, Immunology, Oncology +12

A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion

Shanye Yin, Rutendo Gambe, Jing Sun et al. · Cancer Cell · 2019 · 96 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma

Zachary Cartun, Wolfgang G. Kunz, Lucie Heinzerling et al. · JAMA Dermatology · 2022 · 10 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

1–4 of 4